These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3817924)

  • 1. Autoantibodies to intermediate filaments in acute viral hepatitis.
    Chandra M; Golani DD; Sachdeva S; Bihari N; Sharma DK
    Indian J Med Res; 1986 Sep; 84():247-51. PubMed ID: 3817924
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin.
    Brown C; Pedersen J; Underwood JR; Gust I; Toh BH
    J Clin Lab Immunol; 1986 Jan; 19(1):1-4. PubMed ID: 3084793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical aspects of severe forms of serum hepatitis type B].
    Ketiladze ES; Farber NA; Zhilina NN; Vorozhbieva TE; Savitskiĭ GI
    Klin Med (Mosk); 1980 Jan; 58(1):46-52. PubMed ID: 6966013
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of the clinical forms of hepatitis B in light of the viral-immunogenetic concept of its pathogenesis].
    Sorinson SN; Korochkina OV; Iakhontov NE
    Sov Med; 1984; (5):27-30. PubMed ID: 6463720
    [No Abstract]   [Full Text] [Related]  

  • 5. [T- and B-lymphocytes, M, A and G immunoglobulins in viral hepatitis, liver cirrhosis and HBs-Ag carrier state].
    Belozerov ES; Sagandikov BB; Shabalin VV
    Klin Med (Mosk); 1979 Mar; 57(3):63-5. PubMed ID: 312361
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmunity in chronic liver disease caused by hepatitis delta virus.
    Zauli D; Crespi C; Bianchi FB; Craxi A; Pisi E
    J Clin Pathol; 1986 Aug; 39(8):897-9. PubMed ID: 3745480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of disappearance of HBs antigen from the blood serum of patients with acute hepatitis B on the level of immunoglobulins G, A and M and selected laboratory studies].
    Rzeszowska G; Patorska-Mach E; Mierzejewska I
    Pol Tyg Lek; 1979 Nov; 34(48):1862-4. PubMed ID: 530882
    [No Abstract]   [Full Text] [Related]  

  • 8. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
    Pár A; Barna K; Bajtai G; Hollós I; Ambrus M; Kovács M; Jávor T
    Acta Med Acad Sci Hung; 1980; 37(3):269-81. PubMed ID: 7457030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to intermediate filaments in experimental infections with Trypanosoma brucei gambiense.
    Anthoons JA; Van Marck EA; Gigase PL
    Z Parasitenkd; 1986; 72(4):443-52. PubMed ID: 3529673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-biochemical characteristics of HBsAG-negative acute hepatitis B].
    Mkhitarian AL; Ketiladze ES; Nemtsova EB; Braginskiĭ DM; Viazov SO
    Sov Med; 1989; (7):87-9. PubMed ID: 2799540
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune response in acute viral hepatitis.
    Berg PA
    Clin Gastroenterol; 1974 May; 3(2):255-75. PubMed ID: 4278836
    [No Abstract]   [Full Text] [Related]  

  • 12. [G and M immunoglobulins during acute hepatitis. Quantitative and qualitative studies].
    Berthold H; Stiess G
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):368-71. PubMed ID: 4154613
    [No Abstract]   [Full Text] [Related]  

  • 13. What you need to know: interpreting hepatitis B viral markers.
    Tan CK
    Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kinetics of HBsAg serum level and kinetics of the level of complement as well as of IgG, IgA anf IgM in various forms of viral hepatitis of the B type].
    Loch T
    Przegl Epidemiol; 1978; 32(4):417-28. PubMed ID: 734129
    [No Abstract]   [Full Text] [Related]  

  • 15. [The HbsAg/IgM complex in chronic hepatitis B].
    Stránský J; Zichová M; Vodák M
    Vnitr Lek; 1988 Apr; 34(4):371-5. PubMed ID: 3394262
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic mechanisms of cell damage and pathogenetic correlations in acute and chronic hepatitis].
    Realdi G; Alberti A; Trevisan A; Bortolotti F; Tremolada F; Rigoli AM
    Minerva Med; 1978 Aug; 69(38):2555-67. PubMed ID: 309565
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipid values and immune parameters in the course of viral hepatitis in patients with alcohol abuse and without alcohol stress in anamnesis].
    Boroń P; Sokolewicz-Bobrowska E; Boroń-Kaczmarska A; Borzuchowska A; Szpakowicz T
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):270-7. PubMed ID: 6335426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of the immune system in the symptom-free HBsAg carrier state].
    Mansurov KhKh; Asfandiiarova NS
    Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874
    [No Abstract]   [Full Text] [Related]  

  • 19. [Delta agent infection and immunoglobulin G in acute HBsAg-positive hepatitis with chronic course].
    Tagariello G; Pasquinucci S; Belussi F; Dal Canton A; Alberti A
    Boll Ist Sieroter Milan; 1987; 66(6):485-8. PubMed ID: 3453151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surface antigen (HBsAg) and core antigen (HBcAg) of the Dane particle detected by immunofluorescence in hepatic biopsies in patients with acute and chronic hepatitis].
    Rizzetto M; Bonino F; Toselli M; Verme G
    Minerva Gastroenterol; 1976; 22(3):241-4. PubMed ID: 794760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.